LEGION 100
Live / Applied — New application — not yet assigned to an examiner (as of 26 Jun 2026)
What this means for you
Not registered yet, but its 26 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99908104
- Mark type
- Word mark
- Filed
- 26 Jun 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 010 — Medical apparatus: Medical devices for the treatment of solid tumor cancers which cause partial intratumoral cell lysis and which deliver direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis; Medical apparatus, namely, devices which cause partial intratumoral cell lysis and which permit infusion and injection for locally targeted administration at the site of partial intratumoral lysis of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof
- Class 042 — Scientific and technological services: Providing a website featuring information in the field of clinical trials; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis
- Class 044 — Medical, beauty and agricultural services: Providing a website featuring information in the field of health and medicine; conducting clinical trials of a system for the treatment of solid tumor cancers which causes partial intratumoral cell lysis and which delivers direct infusion of one or more Active Pharmaceutical Ingredients (APIs), whether biological or chemical agents or mixtures and formulations thereof into the tumor or to a localized region of the body at the site of partial intratumoral cell lysis
Owner
- Syncromune, Inc., Fort Lauderdale, FL, US
Prosecution history
- 26 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Jun 2026 — NEW APPLICATION ENTERED